DOPAMINE, SEROTONIN AND SYMPTOMS OF SCHIZOPHRENIA

被引：0

作者：

VINAROVA, E

VINAR, O

机构：

[1] DIST HLTH CTR, DEPT PSYCHIAT, CS-29301 MLADA BOLESLAV, CZECHOSLOVAKIA

[2] STATE DRUG CONTROL INST, CS-10041 PRAGUE 10, CZECHOSLOVAKIA

[3] INST ORGAN CHEM BIOCHEM, JOINT LAB, CS-10041 PRAGUE 10, CZECHOSLOVAKIA

来源：

PSYCHOPHARMACOLOGY | 1988年 / 96卷 / 01期

关键词：

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：S60 / S60

页数：1

共 50 条

[41] The relevance of the dopamine-D1 receptor in the cognitive symptoms of schizophrenia
Goldman-Rakic, PS
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (06) : S170 - S180
[42] Dopamine beta-hydroxylase gene polymorphisms and psychotic symptoms in schizophrenia
Park, J. K.
Kim, J. W.
Lee, H. J.
Chung, J. H.
Ha, E. Y.
Oh, D. J.
Song, J. Y.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2007, 144B (07) : 944 - 945
[43] The Relevance of the Dopamine-D1 Receptor in the Cognitive Symptoms of Schizophrenia
Patricia S Goldman-Rakic
Neuropsychopharmacology, 1999, 21 : S170 - S180
[44] Dopamine D3 receptor and improvement in positive symptoms of schizophrenia
Staddon, S
Arranz, MJ
Mata, I
Munro, J
Osborne, S
Collier, D
Kerwin, R
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (07): : 873 - 873
[45] SEROTONIN AND SCHIZOPHRENIA
IQBAL, N
GOLDSAMT, LA
WETZLER, S
SCHWARTZ, BJ
VANPRAAG, HM
PSYCHIATRIC ANNALS, 1993, 23 (04) : 186 - 192
[46] Serotonin and schizophrenia
Dinan, TG
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1996, 11 : S73 - S74
[47] Serotonin and schizophrenia
Tamminga, CA
BIOLOGICAL PSYCHIATRY, 1998, 44 (11) : 1079 - 1080
[48] Serotonin and schizophrenia
Freeman, HL
JOURNAL OF DRUG DEVELOPMENT AND CLINICAL PRACTICE, 1996, 7 (04): : 253 - 255
[49] CLINICAL-STUDIES ON THE MECHANISM OF ACTION OF CLOZAPINE - THE DOPAMINE-SEROTONIN HYPOTHESIS OF SCHIZOPHRENIA
MELTZER, HY
PSYCHOPHARMACOLOGY, 1989, 99 : S18 - S27
[50] Factors related to weight gain in patients with schizophrenia treated with serotonin-dopamine antagonists
Jang, WSJ
Kim, SKK
Choi, KSC
Park, DYP
Han, WSH
Hong, KSH
Lee, DSL
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S237 - S237

← 1 2 3 4 5 →